Page last updated: 2024-08-24

meglumine antimoniate and Chronic Pain

meglumine antimoniate has been researched along with Chronic Pain in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bordignon, J; Conchon Costa, I; Costa, IN; da Silva, SS; Fanti, JR; Felipe, I; Mizokami, SS; Pavanelli, WR; Verri, WA	1

Other Studies

1 other study(ies) available for meglumine antimoniate and Chronic Pain

Article	Year
Glucantime reduces mechanical hyperalgesia in cutaneous leishmaniasis and complete Freund's adjuvant models of chronic inflammatory pain. The Journal of pharmacy and pharmacology, 2018, Volume: 70, Issue:6 Topics: Acetylglucosaminidase; Animals; Chronic Pain; Cytokines; Freund's Adjuvant; Inflammation; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Mice; Organometallic Compounds; Peroxidase; Skin	2018

Article

Year

Glucantime reduces mechanical hyperalgesia in cutaneous leishmaniasis and complete Freund's adjuvant models of chronic inflammatory pain.

The Journal of pharmacy and pharmacology, 2018, Volume: 70, Issue:6

Topics: Acetylglucosaminidase; Animals; Chronic Pain; Cytokines; Freund's Adjuvant; Inflammation; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Mice; Organometallic Compounds; Peroxidase; Skin

2018